Treatment for Trichomonas Vaginalis
Treat trichomoniasis with oral metronidazole 500 mg twice daily for 7 days in women, or metronidazole 2 g as a single oral dose in men. 1
Primary Treatment Recommendations
For Women
- Preferred regimen: Metronidazole 500 mg orally twice daily for 7 days 1
- Alternative regimen: Metronidazole 2 g orally as a single dose 2, 3
The 7-day regimen is superior for women based on a 2018 randomized controlled trial that demonstrated significantly lower treatment failure rates (11% vs 19%, p<0.0001) compared to single-dose therapy 1. This represents the most recent high-quality evidence and should guide treatment decisions for women.
For Men
- Preferred regimen: Metronidazole 2 g orally as a single dose 4
- Alternative regimen: Metronidazole 500 mg orally twice daily for 7 days 2, 3
Treatment Efficacy
Both regimens achieve cure rates of approximately 90-95% when used appropriately 2, 3, 5. The key difference is that multi-dose therapy performs better in women, while single-dose therapy remains adequate for men.
Critical Management Points
Partner Treatment
Always treat sexual partners concurrently, even without testing 2, 3. This is essential because:
- Partner treatment increases cure rates
- Prevents reinfection
- Reduces transmission
- Instruct patients to avoid sexual contact until both partners complete therapy and are asymptomatic
Treatment Failure Protocol
If initial treatment fails, follow this escalation algorithm 2, 3, 5:
- First failure: Re-treat with metronidazole 500 mg twice daily for 7 days
- Second failure: Metronidazole 2 g once daily for 3-5 days
- Persistent failure: Consult infectious disease specialist and obtain susceptibility testing (CDC consultation available at 770-488-4115)
Special Populations
Pregnancy
- Any trimester: Metronidazole 2 g single dose is safe and recommended 3, 5
- Treating symptomatic trichomoniasis in pregnancy is warranted to prevent preterm birth, premature rupture of membranes, and low birthweight 5, 6
- Multiple studies have not demonstrated teratogenic or mutagenic effects from metronidazole use during pregnancy 5
- Note: Older 1993 guidelines contraindicated first-trimester use 2, but this has been superseded by more recent evidence showing safety
HIV-Infected Patients
Treat with the same regimens as HIV-negative patients 2, 3, 5. However, HIV-infected women may benefit from the 7-day regimen given higher treatment failure rates in this population 7.
Metronidazole Allergy
- No effective alternatives exist 2, 3
- Desensitization is the only option for true allergy 3, 5
- Topical therapies have cure rates <50% and are not recommended 5
Important Caveats
Do NOT Use Topical Metronidazole
Metronidazole gel (approved for bacterial vaginosis) has efficacy <50% for trichomoniasis because it cannot achieve therapeutic levels in the urethra or perivaginal glands 3, 5. Only oral metronidazole is effective.
Follow-Up Testing
- Routine test-of-cure is NOT recommended for asymptomatic patients after treatment 2, 3, 6
- Rescreening at 3 months is recommended due to high reinfection rates 4
- Only perform test-of-cure if symptoms persist
Antimicrobial Resistance
Metronidazole resistance occurs in approximately 4-5% of cases 4, 7, 8. Most resistant strains respond to higher doses using the treatment failure protocol above. True resistance requiring susceptibility testing is rare but increasing.
Clinical Presentation
Women typically present with malodorous yellow-green discharge and vulvar irritation, while most men are asymptomatic 2, 3. The infection is associated with increased HIV acquisition risk, cervical cancer, and adverse pregnancy outcomes 4, 7.